LSL Pharma Group Inc.
LSL.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 121.40K | 211.20K | -- | 6.10K | -- |
| Total Receivables | 2.51M | 2.39M | 2.52M | 2.03M | 1.30M |
| Inventory | 4.16M | 3.88M | 3.15M | 3.11M | 2.86M |
| Prepaid Expenses | 509.30K | 738.00K | 834.50K | 306.70K | 297.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.31M | 7.22M | 6.51M | 5.46M | 4.46M |
|
|
|||||
| Total Current Assets | 7.31M | 7.22M | 6.51M | 5.46M | 4.46M |
| Net Property, Plant & Equipment | 14.01M | 13.14M | 11.20M | 11.17M | 11.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.76M | 6.63M | 6.63M | 6.76M | 6.45M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.80K | 14.60K | 15.50K | 15.10K | 14.80K |
| Total Assets | 28.10M | 27.00M | 24.35M | 23.40M | 21.92M |
|
|
|||||
| Total Accounts Payable | 2.60M | 2.75M | 3.14M | 3.72M | 3.04M |
| Total Accrued Expenses | -- | -- | -- | 802.60K | -- |
| Short-term Debt | 380.50K | 496.10K | 910.60K | 2.85M | 966.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.29M | 3.55M | 3.39M | 4.04M | 5.11M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 1.41M |
| Total Other Current Liabilities | -- | -- | -- | -- | 1.41M |
| Total Current Liabilities | 6.26M | 6.80M | 7.44M | 11.41M | 10.52M |
|
|
|||||
| Total Current Liabilities | 6.26M | 6.80M | 7.44M | 11.41M | 10.52M |
| Long-Term Debt | 4.83M | 4.22M | 4.30M | 3.58M | 2.36M |
| Short-term Debt | 380.50K | 496.10K | 910.60K | 2.85M | 966.60K |
| Capital Leases | 1.90M | 1.72M | 1.77M | 1.85M | 1.83M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.40K | 30.70K | -- | -- | -- |
| Total Liabilities | 13.02M | 12.77M | 13.52M | 16.84M | 14.71M |
|
|
|||||
| Common Stock & APIC | 29.17M | 27.86M | 24.23M | 20.08M | 20.34M |
| Retained Earnings | -14.37M | -13.90M | -13.67M | -13.81M | -13.13M |
| Treasury Stock & Other | 277.60K | 274.00K | 276.90K | 284.00K | -- |
| Total Common Equity | 15.08M | 14.23M | 10.83M | 6.55M | 7.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.08M | 14.23M | 10.83M | 6.55M | 7.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.08M | 14.23M | 10.83M | 6.55M | 7.21M |
|
|
|||||
